why am i gaining weight on retatrutide 30 Days of — LessWrong if your not losing weight
Description
Our programs are designed not just for short-term results but for building healthier lives
They also skip over the Zepbound maintenance dose after goal weight which is individualized
It's worth noting that tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist, representing a distinct but related medication class with similar clinical effects
Other oral are in FDA review and could hit the market in 2024
